Low-molecular-weight heparin for treatment of submassive pulmonary embolism after pneumonectomy

Pulmonary embolism (PE) after lung resection has a high mortality rate, and it is one of the most severe complications after lung resection. Early diagnosis and treatment are essential. We present a case of severe PE after left pneumonectomy for lung cancer. Computed tomography angiography was usefu...

Full description

Saved in:
Bibliographic Details
Published inGeneral thoracic and cardiovascular surgery Vol. 55; no. 7; pp. 287 - 289
Main Authors Kilic, Dalokay, Akin, Sule, Findikcioglu, Alper, Bilen, Ahmet, Aribogan, Anis, Hatipoglu, Ahmet
Format Journal Article
LanguageEnglish
Published Japan Springer Nature B.V 01.07.2007
Subjects
Anticoagulants - therapeutic use
Heparin, Low-Molecular-Weight - therapeutic use
Humans
Male
Middle Aged
Pneumonectomy
Postoperative Complications
Pulmonary Embolism - drug therapy
Online AccessGet full text

Cover

More Information
Summary:Pulmonary embolism (PE) after lung resection has a high mortality rate, and it is one of the most severe complications after lung resection. Early diagnosis and treatment are essential. We present a case of severe PE after left pneumonectomy for lung cancer. Computed tomography angiography was useful for confirming the diagnosis of PE. Low-molecular-weight heparin (LMWH) was used to treat the embolism, and the patient was discharged on the seventh day. LMWH is an effective and safe agent for the treatment of PE after pneumonectomy and may reduce the need for surgery. It may be used as an initial procedure. Secondary severe complications, including hemorrhage and subsequent empyema, may be avoided with the use of LMWH.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1863-6705
1863-6713
DOI:10.1007/s11748-007-0124-8